Searcharxiv⌕ Search
Home/Archive/arXiv

arXiv · 2610.14642

Bayesian Uncertainty Quantification of Breast-Cancer Pathology AI Agreement under Reader- and Annotation-Condition-Dependent Reference Labels

Hammed A. Olayinka
View original source ↗Read source document ↗Export metadata ↓

Abstract

Human reference labels used to evaluate medical AI can vary across readers and annotation workflows. We quantified agreement of a fixed pathology AI system with a future qualified reader without treating inferred consensus as error-free biological truth. Linked Evaluation and Unbiased NuCLS multirater data were analyzed using a fixed external HoVer-Net decision vector. The selected frame contained 1,144 anchors, 52 fields of view, five slides/patients, and five primary readers. The target was fixed-AI agreement with a future reader, with descriptive contrast $Δ=θ_E-θ_U$. Analyses included raw agreement and iMRMC benchmarks, reader-only and shared-detectability Bayesian models, structural sensitivities, adversarial simulations, and predictive assessment. Among 5,188 reader-anchor pairs observed in both conditions, 19.62% changed AI-agreement state, while raw agreement was 0.5466 in Unbiased and 0.5473 in Evaluation. The reader-only model gave $Δ=-0.0008$ (95% CrI, $-0.0033$ to $0.0008$), and the shared-detectability model gave $Δ\approx0$ ($-0.0140$ to $0.0127$). Across structural perturbations, absolute agreement ranged from 0.420 to 0.646 in Unbiased and 0.409 to 0.640 in Evaluation. Frozen adversarial simulations met the comparative-stability criterion (median $R=0.295$; 14/16 model-scenario cells had $R<1$). Held-out-AI prediction supported shared predictive information, but varied by slide composition. The Evaluation-minus-Unbiased contrast was comparatively stable, whereas absolute agreement was structurally sensitive. These findings do not establish equivalence, causal assistance effects, biological accuracy, or new-patient transportability. Evaluations using variable human references should report reader population, selected frame, observation mechanism, and structural sensitivity.

Explore related subjects

q-bio.QMstat.APstat.COstat.ME

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hammed A. Olayinka. 2026-10-10. Bayesian Uncertainty Quantification of Breast-Cancer Pathology AI Agreement under Reader- and Annotation-Condition-Dependent Reference Labels. https://arxiv.org/abs/2610.14642

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

An efficient and flexible generalization of transit compartment models for delayed biological processes

Transit compartment models are widely used in pharmacokinetics/pharmacodynamics to represent delayed biological processes such as absorption, maturation, cellular proliferation, and treatment-induced toxicity. This transit compartment formulation imposes an artificial relationship between the mean and variance of the delay distribution, as the number of transit compartment must be integer-valued number of transit compartments. Consequently, estimating the number of compartments from experimental data leads to mixed-integer optimization problems that artificially constrain model dynamics and bias parameter inference. However, these transit compartment models are mathematically equivalent to distributed delay differential equations with Erlang delay kernels. We leverage a hypoexponential generalization of these distributed delay differential equations that preserves the familiar ordinary differential equation structure while allowing the mean and variance of the delay distribution to be estimated directly as real-valued parameters. This approach does not increase the number of inferred parameters and can be immediately implemented as a straightforward modification of existing transit compartment models. We demonstrate the approach using models of viral eclipse phases, lymphocyte proliferation, and chemotherapy-induced neutropenia. Across these examples, the hypoexponential formulation provides comparable or improved fits relative to Erlang transit models and substantially reduces computational cost by avoiding grid search over compartment numbers. This framework provides a practical approach to estimate biologically meaningful delay distributions in quantitative systems pharmacology (QSP) models.

q-bio.QM↗
arXiv2026

STAMP as a topology-aware molecular language for fragment-level learning and editing

Molecular fragments provide chemically meaningful units, but existing molecular languages rarely make their locations and connections explicit for editing. Here we introduce STAMP (Sequential Tree Attachment-based Motif-Preserving representation), a topology-aware molecular language that connects fragment-level representation learning with precise structural editing. STAMP separately encodes motif identity, attachment sites and tree topology, making fragments reusable across contexts and subtrees directly accessible. Learned representations capture motif similarity and recurring transformations, and lower activity-cliff prediction error on 23 of 30 targets versus a matched SMILES encoder. Compatible subtree operations support scaffold-preserving optimization, ranking first among six methods on 15 of 23 benchmark objectives. A deterministic compiler enables frozen language models to act on indexed fragments, improving molecular editing, optimization, transformation transfer and change identification by 9 to 56 percentage points over plain SMILES. Together, these results establish an executable molecular language in which learned chemical units remain directly operable during design.

q-bio.QM↗
arXiv2026

Brain Age Gap Progression in Individuals at Risk for Neurodegeneration

Neuroimaging is a widely used modality for characterizing neurodegeneration in various health conditions. Brain age gap has emerged as a promising biomarker for monitoring brain health from neuroimaging data using machine learning algorithms. Recent studies have leveraged coVariance neural networks (VNN)-driven pipelines based on the advancements in graph signal processing for relatively transparent construction of brain age gap from neuroimaging data. In this paper, we focus on a longitudinal study of VNN-based brain age gap in conjunction with Alzheimer's Progression Score (APS) in individuals that are at a higher risk of neurodegeneration due to family history of Alzheimer's disease. APS is a multimodal marker of disease progression. The longitudinal analysis of APS and VNN-derived brain age gap metrics revealed that a higher risk of disease progression at baseline predicted a larger rate of increase in brain age gap in follow-up visits. Thus, our findings revealed potential stratification in the brain age gap modulated by clinical/biological risks of AD in the at-risk population.

q-bio.QM↗